Invitrogen

RAC1 Polyclonal Antibody

10个已发表图片

27 篇参考文献

查看其他11个RAC1抗体

问题与答案

问题与答案

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

图: 1 / 22

RAC1 Antibody (PA1-091X) in ICC/IF

Immunofluorescence analysis of RAC1 was performed using 70% confluent log phase HeLa cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 2% BSA for 45 minutes at room temperature. The cells were labeled with RAC1 Polyclonal Antibody (Product # PA1-091X) at 1:100 dilution in 0.1% BSA, incubated at 4 degree celsius overnight and then labeled with Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (Product # A32790)... View More

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunohistochemistry (Paraffin) (IHC (P))

RAC1 Antibody in Immunohistochemistry (IHC)

RAC1 Antibody in Immunohistochemistry (IHC)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunocytochemistry (ICC/IF)

RAC1 Antibody in Immunohistochemistry (IHC)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

RAC1 Antibody in Western Blot (WB)

Product Image Gallery

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescence analysis of RAC1 was performed using 70% confluent log phase HeLa cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 2% BSA for 45 minutes at room temperature. The cells were labeled with RAC1 Polyclonal Antibody (Product # PA1-091X) at 1:100 dilution in 0.1% BSA, incubated at 4 degree celsius overnight and then labeled with Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (Product # A32790), (1:2000 dilution), for 45 minutes at room temperature (Panel a: Green). Nuclei (Panel b:Blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI (Product # P36962). F-actin (Panel c: Red) was stained with Rhodamine Phalloidin (Product # R415, 1:300 dilution). Panel d represents the merged image showing cytoplasmic localization. Panel e represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescent analysis of Rac1 (green) in untreated HeLa cells. Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature. Cells were then blocked with 5% normal goat serum (Product # 31873) for 15 minutes at room temperature. Cells were probed with a rabbit polyclonal antibody recognizing Rac1 (Product # PA1-091X), at a dilution of 1:100 for at least 1 hour at room temperature. Cells were then washed with PBS and incubated with DyLight 488 goat-anti-rabbit secondary antibody at a dilution of 1:400 for 30 minutes at room temperature. Nuclei (blue) were stained with Hoechst 33342 dye (Product # 62249). Images were taken on a Thermo Scientific ArrayScan at 20X magnification.

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescent analysis of Rac1 (green) in Hela cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a Rac1 polyclonal antibody (Product # PA1-091X) at a dilution of 1:100 and incubated overnight in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark. F-actin (red) was stained with a fluorescent phalloidin and nuclei (blue) were stained with DAPI. Images were taken at a 60X magnification.

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescent analysis of Rac1 (green) in murine cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a Rac1 polyclonal antibody (Product # PA1-091X) at a dilution of 1:20 and incubated overnight in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark. F-actin (red) was stained with a fluorescent phalloidin and nuclei (blue) were stained with DAPI. Images were taken at a 60X magnification.

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Immunofluorescent analysis of Rac1 (green) in human cells. Formalin-fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 5-10 minutes at room temperature and blocked with 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a Rac1 polyclonal antibody (Product # PA1-091X) at a dilution of 1:20 and incubated overnight in a humidified chamber. Cells were washed with PBST and incubated with a DyLight-conjugated secondary antibody for 45 minutes at room temperature in the dark. F-actin (red) was stained with a fluorescent phalloidin and nuclei (blue) were stained with DAPI. Images were taken at a 60X magnification.

RAC1 Antibody in Immunohistochemistry (Paraffin) (IHC (P)) — Immunohistochemistry was performed on human prostate tissue. To expose target protein, antigen was retreived using 10mM sodium citrate followed by microwave treatment for 8-15 minutes. Endogenous peroxidases were blocked in 3% H202-methanol for 15 minutes and tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a Rac-1 Rabbit polyclonal antibody (Product # PA1-091X) at a dilution of 1:50 overnight in a humidified chamber. Tissues were washed in PBST and detection was performed using a secondary antibody conjugated to HRP. DAB staining buffer was applied and tissues were counterstained with hematoxylin and prepped for mounting. Images were taken at 40X magnification.

RAC1 Antibody in Immunohistochemistry (IHC) — Immunohistochemistry was performed on human breast tissue. To expose target protein, antigen was retreived using 10mM sodium citrate followed by microwave treatment for 8-15 minutes. Endogenous peroxidases were blocked in 3% H202-methanol for 15 minutes and tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a Rac-1 Rabbit polyclonal antibody (Product # PA1-091X) at a dilution of 1:200 overnight in a humidified chamber. Tissues were washed in PBST and detection was performed using a secondary antibody conjugated to HRP. DAB staining buffer was applied and tissues were counterstained with hematoxylin and prepped for mounting. Images were taken at 40X magnification.

RAC1 Antibody in Immunohistochemistry (IHC) — Immunohistochemistry was performed on human tonsil tissue. To expose target protein, antigen was retreived using 10mM sodium citrate followed by microwave treatment for 8-15 minutes. Endogenous peroxidases were blocked in 3% H202-methanol for 15 minutes and tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a Rac-1 Rabbit polyclonal antibody (Product # PA1-091X) at a dilution of 1:50 overnight in a humidified chamber. Tissues were washed in PBST and detection was performed using a secondary antibody conjugated to HRP. DAB staining buffer was applied and tissues were counterstained with hematoxylin and prepped for mounting. Images were taken at 40X magnification.

RAC1 Antibody in Western Blot (WB) — Western blot was performed using Anti-RAC1 Polyclonal Antibody (Product # PA1-091X) and a 21kDa band corresponding to RAC1 was observed along with uncharacterized band (*) across cell lines tested. Membrane enriched extracts (30 µg lysate) of HeLa (Lane 1), HT-29 (Lane 2), SW480 (Lane 3), PC-3 (Lane 4), LNCaP (Lane 5), A-431 (Lane 6) and NIH/3T3 (Lane 7) were electrophoresed using NuPAGE™ 4-12% Bis-Tris Protein Gel (Product # NP0321BOX). Resolved proteins were then transferred onto a Nitrocellulose membrane (Product # IB23001) by iBlot® 2 Dry Blotting System (Product # IB21001). The blot was probed with the primary antibody (1:1000 dilution) and detected by chemiluminescence with Goat anti-Rabbit IgG (Heavy Chain) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A27036, 1:4000 dilution) using the iBright FL 1000 (Product # A32752). Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005).

RAC1 Antibody in Western Blot (WB) — Knockdown of RAC1 was achieved by transfecting HT-29 with RAC1 specific siRNAs (Silencer® select Product # S11713). Western blot analysis (Fig. a) was performed using Membrane enriched extracts from the RAC1 knockdown cells (lane 3), non-targeting scrambled siRNA transfected cells (lane 2) and untransfected cells (lane 1). The blot was probed with RAC1 Polyclonal Antibody (Product # PA1-091X, 1:1000 dilution) and Goat anti-Rabbit IgG (Heavy Chain) Superclonal™ Recombinant Secondary Antibody, HRP (Product # A27036, 1:4000 dilution). Densitometric analysis of this western blot is shown in histogram (Fig. b). Decrease in signal upon siRNA mediated knock down confirms that antibody is specific to RAC1.

RAC1 Antibody in Western Blot (WB) — Western blot analysis of Rac1 was performed by loading 50 µg of various whole cell lysate onto a 4-20% Tris-HCl polyacrylamide gel. Proteins were transferred to a PVDF membrane and blocked with 5% BSA/TBST for at least 1 hour. Membranes were then probed with a rabbit polyclonal antibody recognizing Rac1 (Product # PA1-091X) at a dilution of 1:1000 overnight at 4°C on a rocking platform. Membranes were then washed in TBS-0.1%Tween 20 and probed with a goat anti-rabbit-HRP secondary antibody (Product # 31460) at a dilution of 1:15000 for at least one hour. Membranes were washed and chemiluminescent detection was performed using Super Signal West Pico (Product # 34080).

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Rac1-Nox2 colocalization and inhibition of SPT. ( a ) Rac1 and Nox2 were determined by immunofluorescence using DyLight green (green)-conjugated and Texas Red (red)-conjugated secondary antibodies, respectively. The line marker represents 20um. 'Arithmetic mean intensity' (AMI) of ( b ) Nox2 and ( c ) Rac1 was quantified by Zeiss software, from 5 to 8 images/group. ( d ) Zeiss software module was used to calculate Pearson's correlation coefficient between Rac1 and Nox2. The values in the graph are mean +- SD, obtained from 3-4 different cell preparations with multiple cells analyzed in each preparation. *p < 0.05 vs NG, # p < 0.05 vs HG and # **p < 0.05 vs HG + PA.

RAC1 Antibody in Immunocytochemistry (ICC/IF) — Published figure using RAC1 polyclonal antibody (Product # PA1-091X) in Immunocytochemistry

RAC1 Antibody in Immunohistochemistry (IHC) — The effects of delayed overexpression of cerebral Ras-related C3 botulinum toxin substrate (Rac) 1 on functional recovery after ischemic stroke in aged mice. (A) Immunohistochemical assessment of Rac1 (Alexa Fluor 594 in red) on day 28 after stroke. Blue indicated cell nucleus staining using 4',6-diamidino-2-phenylindole (DAPI). n = 4/group. * P < 0.05, vs . LV-blank group. (B, C) cognitive function assayed by novel object recognition test (* P < 0.05; B) and sensorimotor function assayed by adhesive removal test (C; ### P < 0.001, pre-stroke vs . 7 days after stroke in control vector group; * P < 0.05, vs . LV-Rac1 group). n = 9/group. Data are presented as the mean +- SEM. For immunohistochemistry, Mann-Whitney U test was used. For behavior outcome, two-way analysis of variance with post hoc Bonferonni test was used. LV-blank: Control vector; LV-Rac1: lentiviral vector encoding Rac1.

RAC1 Antibody in Western Blot (WB) — The protein level of Ras-related C3 botulinum toxin substrate (Rac) 1 in the cerebral hemisphere of aged mice. The protein level of Ras-related C3 botulinum toxin substrate (Rac) 1 was quantified by Western blotting. Relative protein expression was normalized to beta-actin. n = 3/group. Data are presented as the mean +- SEM. * P < 0.05, vs . young mice (Mann-Whitney U test).

RAC1 Antibody in Western Blot (WB) — Fig. 5 RAC1 co-localizes with ER on chromatin. A MCF-7 cells were treated as in Fig. 4A . The cell extract was fractionated into different portions and analyzed by Western blotting with the indicated antibodies. T total cellular lysate, C cytoplasmic fraction, N nuclear soluble fraction, Chr chromatin. B MCF-7 cells were cultured in estrogen-deprivation media for three days followed by the treatment with 10 nM E2 for 45 min. No E2-treated sample (cFBS) was served as a control. ChIP-qPCR analyses were performed for chromatin occupancies of ER, SRC-3, or RAC1, at a target region within the GREB1 enhancer. * P < 0.0001, compared to each control sample (Student's t test). C ChIP-seq analyses were performed for ER, SRC-3, RAC1, and RNA pol II, using MCF-7 samples prepared as in ( B ). Target occupancies at the GREB1 enhancer region were shown in IGV genome browser tracks. D Venn diagram of identified RAC1 chromatin occupancy sites (derived from two biological replicate samples, q < 10 -10 ) in the presence or absence of E2. E The average profiles and heatmaps of RAC1 signals at three groups of RAC1 occupancy sites as separated in ( D ). Homer motif analysis indicated enriched motifs at RAC1 sites only detected with E2 treatment ( F ) or motifs at RAC1 sites commonly detected with or without E2 ( G ). H Venn diagram of the overlapping of occupancy sites for ER, SRC-3 or RAC1 (derived from two biological replicate samples, q < 10 -10 ) in the presence of E2. I The average profiles a

RAC1 Antibody in Western Blot (WB) — Fig. 5 Rac1 is involved in CAP2-mediated ERK activation and EMT. (A and B) SNU423-Vector and SNU423- CAP2 cells are stained with the indicated fluorescent antibodies. Nuclei are counter-stained with DAPI. Images are captured under a laser scanning confocal microscope (x40). White arrows indicate membrane ruffles. Scale bars = 10 mum. (C) Total cell lysates prepared from the indicated cells are incubated with agarose beads coupled to PAK PBD. Bound Rac1 is detected with Western blotting using a Rac1 Ab (upper panel). The amount of total Rac1 is also measured (lower panel). P.C, positive control; N.C, negative control. Asterisks (*) indicate CAP2. (D) SNU423-Vector and SNU423- CAP2 cells were treated for 24 h with NSC23766 (50 muM) and subjected to western blotting with the indicated antibodies. Asterisk (*) indicates CAP2, double asterisk (**) indicates Snail. (E) SNU423- CAP2 and Huh7- CAP2 cells stably expressing Vector (Vec), Rac1 -WT, Rac1 -Q61L, or Rac1 -N17 are subjected to Western blotting with the indicated antibodies. Asterisks (*) indicate CAP2. (F) Migration and invasion of the indicated cells were measured in Transwell assays. Migrated/invaded cells are fixed with 10% formaldehyde and stained with 1% crystal violet. WT, wild type. Images are captured under a light microscope (magnification, x5). Scale bars = 500 mum. Data are presented as mean +- SEM for triplicate experiments. * P < 0.05, ** P < 0.01, and *** P < 0.001.

RAC1 Antibody in Western Blot (WB) — Figure 3 The effect of NecroX-5 treatment on the expression of Rho family GTPases (Cdc42, Rac1, and RhoA). A375P ( A - F ) and A375SM ( G - L ) were treated with 10 muM or 20 muM NecroX-5 for 24 h. The mRNA expression levels of Cdc42, Rac1, and RhoA were measured by qRT-PCR ( A - C , G - I ). The protein levels of Cdc42, Rac1, and RhoA were measured using western blot analysis ( D - F , J - L ). GAPDH was used as an internal control for mRNA and protein normalization (ZCL278 (10 muM), Cdc42 GTPase inhibitor; NCS23766 (10 muM), Rac GTPase inhibitor; CCG-1423 (100 nM), RhoA GTPase inhibitor). Results are expressed as the mean +- SEM from three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001.

RAC1 Antibody in Western Blot (WB) — FIGURE 6 FLNA is a substrate of Pak1, and the effects of FLNA mutations [FLNA (P637Q) and FLNA (G288R)] on PN induced FLNA phosphorylation, on activation of Rac1, and on cell migration are shown. (A) VICs were transfected with FLNA shRNA. The stable clones were isolated and designated as FLNA-deficient VICs (VICs Delta FLNA) WT VICs and FLNA Delta VICs were transfected with vector or with wild-type FLNA lentiviral constructs for 72 h before treatment. These transfected VICs were then embedded in three-dimensional collagen matrices to analyze collagen lattice compaction (see the "Materials and Methods" section for details). (B) Transwell migration assays are shown for WT VICs and VICs Delta FLNA pre-transfected with the indicated lentiviral constructs. Percentages of cells seeded in the upper chamber of Transwell filters that migrated overnight into the lower chamber are shown. Numbers of migrated cells were counted on six fields from three experiments. Detailed descriptions are in the "Materials and Methods" section. (C) Western blot analyses are shown for FLNA and beta-actin (internal control) proteins in the lysates from WT VICs and VICs Delta FLNA pretransfected with the indicated lentiviral constructs. (D) Validation was done for the FLNA shRNAs used in the experiments of (A-C) . Two shRNAs (shRNA1 and shRNA2) were used for the FLNA protein. For a detailed description, see the "Materials and Methods" section. Both shRNAs effectively silenced FLNA gene expression by

RAC1 Antibody in Western Blot (WB) — Figure 4 Activity changes of Rac1 and RhoA upon EMT and related changes in cortical mechanics. Rac1 and RhoA activity before and after EMT: a) Western blots showing GTP-bound Rac1 (top row) and RhoA (third row) before and after EMT. b) Quantification of relative changes of Rac1-GTP and RhoA-GTP from Western blots in (a). Quantifications were normalized by GAPDH band. c-e) Effect of Rac1 and RhoA knock-down on cortex mechanics in MCF-7 and modMCF-7 (post-EMT) in suspended interphase MCF-7 cells (top row) and MCF-7 cells in mitotic arrest (bottom row). f-h) Effect of RhoA activation upon 2 h treatment with 0.5 µg mL -1 RhoA activator II (RhoA-II) and Rac1 inhibition upon 1 h treatment with 100 x 10 -6 m NSC23766 (NSC) on cortex mechanics in modMCF-7 (post-EMT) in suspended interphase MCF-7 cells (top row) and MCF-7 cells in mitotic arrest (bottom row). The last condition was compared to the first condition. (Post-EMT MCF-7 cells are referred to as modMCF-7. Blue-shaded boxes indicate post-EMT conditions. Number of cells measured in (c-e): Interphase: MCF-7 n = 36, esiRhoA n = 36, esiRac1 n = 35, modMCF-7 n = 31, esiRhoA n = 26, and esiRac1 n = 30, Mitosis: MCF-7 n = 22, esiRhoA n = 26, esiRac1 n = 24, modMCF-7 n = 28, esiRhoA n = 28, and esiRac1 n = 28; in (f-h): Interphase: MCF-7 n = 24, modMCF-7 n = 24, NSC n = 22, RhoA-II n = 22, and NSC + RhoA-II n = 24. Mitosis MCF-7 n = 24, modMCF-7 n = 28, NSC n = 22, RhoA-II n = 24 and NSC + RhoA-II n = 22. Measurements are repres

RAC1 Antibody in Western Blot (WB) — Fig. 3. Effects of miR-27a on the expression of migration and invasion-related proteins in RA-FLS. RA-FLS were transfected with miR-27a mimic or miR-27a inhibitor. (A) The protein and mRNA expression of MMP2, MMP9, and MMP13 in RA-FLS was detected by western blot and qRT-PCR assay. (B) The protein and mRNA expression of Rac1, Cdc42, and RhoA in RA-FLS was detected by western blot and qRT-PCR assay. * p < 0.05, versus control mimic group. # p < 0.05, versus control inhibitor group.

RAC1 Antibody — Figure 1 Rac1 is overexpressed in breast cancer cells. (a) Upper panel: normal mammary epithelial cells (76N) and breast cancer cells of subtype luminal A (MCF-7 and T47D), and luminal B (BT-474 and ZR-75-1), triple-negative (MDA-MB-231 and MDA-MB-468) and HER2 positive (SkBr3, HCC1954, 21MT-1) were analyzed for Rac1 protein expression by Western blot analysis. As a protein loading control, the level of GAPDH in cell lysates was assessed. Lower panel: immunoblot densities of Rac1 and GAPDH were quantified using ImageJ analytical program (NIH) and relative Rac1 expression versus GAPDH determined. (b) Representative IHC analysis shows a distinct increase in immunostaining of Rac1 in malignant breast tumor tissues compared to normal breast tissues. (c) Box plot shows composite score of Rac1 expression in normal breast/benign tumor tissues (NT) and cancerous breast tissue (Cancer), analyzed by IHC. {TM}

Immunogen image

RAC1 Polyclonal Antibody

Immunogen Image RAC1 Polyclonal Antibody

产品信息

PA1-091X

应用

建议稀释比

已发表文章

免疫印迹 (WB)

1:1,000

查看18篇已发表文章 18篇已发表文章

免疫组化 (IHC)

-

查看3篇已发表文章 3篇已发表文章

免疫组化（石蜡） (IHC (P))

1:20-1:50

-

免疫细胞化学 (ICC/IF)

1:20-1:100

查看4篇已发表文章 4篇已发表文章

免疫沉淀 (IP)

-

查看1篇已发表文章 1篇已发表文章

亲和纯化 (AP)

-

查看1篇已发表文章 1篇已发表文章

产品规格

种属反应

Human, Mouse

已发表种属

C. elegans, Human, Mouse, Rat

宿主/亚型

Rabbit / IgG

分类

Polyclonal

类型

Antibody

抗原

Recombinant Full-length Human Protein

查看免疫原

偶联物

Unconjugated Unconjugated Unconjugated

形式

Liquid

浓度

1 mg/mL

纯化类型

Antigen affinity chromatography

保存液

PBS with 1mg/mL BSA, 30% glycerol

内含物

0.05% sodium azide

保存条件

-20°C

运输条件

Ambient (domestic); Wet ice (international)

靶标信息

The protein encoded by this gene is a GTPase which belongs to the RAS superfamily of small GTP-binding proteins. Members of this superfamily appear to regulate a diverse array of cellular events, including the control of cell growth, cytoskeletal reorganization, and the activation of protein kinases. Two transcript variants encoding different isoforms have been found for this gene.

仅用于科研。不用于诊断过程。未经明确授权不得转售。

生物信息学

蛋白别名: Cell migration-inducing gene 5 protein; MGC111543; p21-Rac1; Ras-like protein TC25; Ras-related C3 botulinum toxin substrate 1

查看更多收起

基因别名: AL023026; D5Ertd559e; MIG5; p21-Rac1; Rac-1; RAC1; TC-25; TC25

查看更多收起

UniProt ID: (Human) P63000, (Mouse) P63001

查看更多收起

Entrez Gene ID: (Human) 5879, (Mouse) 19353

查看更多收起

GTPase activity protein binding GTP binding Rab GTPase binding enzyme binding protein kinase binding GTP-dependent protein binding thioesterase binding histone deacetylase binding Rho GDP-dissociation inhibitor binding nucleotide binding immunoglobulin small GTPase

positive regulation of protein phosphorylation auditory receptor cell morphogenesis mast cell chemotaxis epithelial cell morphogenesis movement of cell or subcellular component inflammatory response hyperosmotic response cell adhesion cell-matrix adhesion G-protein coupled receptor signaling pathway small GTPase mediated signal transduction axon guidance blood coagulation cell proliferation regulation of cell size response to wounding anatomical structure morphogenesis regulation of hydrogen peroxide metabolic process positive regulation of lamellipodium assembly regulation of fibroblast migration positive regulation of cell-substrate adhesion regulation of neuron maturation cerebral cortex radially oriented cell migration embryonic olfactory bulb interneuron precursor migration cerebral cortex GABAergic interneuron development lamellipodium assembly actin cytoskeleton organization actin filament polymerization platelet activation regulation of cell migration positive regulation of actin filament polymerization T cell costimulation ruffle organization negative regulation of interleukin-23 production substrate adhesion-dependent cell spreading positive regulation of Rho protein signal transduction intracellular signal transduction Fc-epsilon receptor signaling pathway Fc-gamma receptor signaling pathway involved in phagocytosis positive regulation of apoptotic process positive regulation of phosphatidylinositol 3-kinase activity engulfment of apoptotic cell cell-cell junction organization bone resorption positive regulation of DNA replication vascular endothelial growth factor receptor signaling pathway ephrin receptor signaling pathway negative regulation of receptor-mediated endocytosis anatomical structure arrangement dendrite morphogenesis cell motility homeostasis of number of cells within a tissue regulation of defense response to virus by virus regulation of small GTPase mediated signal transduction positive regulation of stress fiber assembly localization within membrane positive regulation of focal adhesion assembly synaptic transmission, GABAergic Wnt signaling pathway, planar cell polarity pathway regulation of respiratory burst cellular response to mechanical stimulus semaphorin-plexin signaling pathway dopaminergic neuron differentiation protein localization to plasma membrane positive regulation of neutrophil chemotaxis cochlea morphogenesis ruffle assembly positive regulation of substrate adhesion-dependent cell spreading endocytosis phagocytosis, engulfment chemotaxis cytoskeleton organization actin filament organization metabolic process dendrite development cell migration regulation of cell morphogenesis